AI Designs Molecules for Precision Cancer Therapies

Scientists at IRB Barcelona have developed a computational framework using predictive and generative artificial intelligence to design molecules for specific cell-targeting therapies ^[1][2]. The system creates chemical entities that identify and target specific cells, such as cancer cells, without requiring a predefined molecular target ^[2]. This method allows researchers to focus on the cellular destination rather than a specific protein interaction ^[3].

The framework combines two distinct AI types to streamline the discovery of effective chemical structures ^[2]. By automating the design of selective molecules, the team aims to reduce side effects in patients by ensuring treatments only interact with diseased cells ^[1][3]. This approach could significantly accelerate the development of personalized medicines for various complex diseases ^[2].